Relapse/Refractory Lymphoma
1 clinical trials · Condition
◉ Watch Relapse/Refractory Lymphoma
| Record | Firm | Date |
|---|---|---|
| First in Human Study of EMB-07 in Locally Advanced/Metastatic Solid Tumors or Relapse/Refractory Lymphoma (NCT05607498) | EpimAb Biotherapeutics (Suzhou)Co., Ltd. | 2023-03-01 |
Track Relapse/Refractory Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.